Revamping Clinical Research

The demand for research services is rising in pharmaceutical, biotechnology, and medical device sectors. CROs are playing a key role in fulfilling this demand resulting from multiple factors such as increased investments in the development of biologics and biosimilars. Noticing the rapid development of this sector, we have focused on it in this special issue. The cover story of this issue features Dabur Research Foundation (DRF) which has positioned itself prolifically in the market to assist in acceleration of drug development projects in several therapeutic areas including oncology, inflammation, dermapathology, cognitive health, auto-immune conditions, gut health, and more recently in the wellness space. It is a premier Indian research organization established in 1979 with a mission to create an ecosystem in the country to bring together the best scientific capabilities to develop innovative health care solutions nationally and globally. Also featuring in the issue is Edara Research Foundation (ERF) which is a new CRO with a global customer base in over 20 nations. ERF has amassed a substantial clientele in a relatively short period of time and it has been working with them successfully. The issue also covers Prado which is one of the leading, global, independent market leaders in toxicity testing and preclinical services, with the goal of providing the highest possible quality preclinical services and contributing towards generations of safe and cost-effective healthcare product development.

In addition, the issue also acquaints you with the other top companies in this field. After studying the industry landscape in-depth, we have zeroed in on the top 10 companies that have excelled in this domain with their meticulous approach. Having proven their dedication to efficiency in order to meet the customer expectations in an end-to-end manner, these companies have stood out from the crowd.

We look forward to receiving your feedback and suggestions.